Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture

The influences of the synthetic progestin, medroxyprogesterone acetate (MPA), the progesterone receptor modulator J867, and the antagonist ZK137316 were studied in vitro on isolated endometrial epithelial cells, as well as endometrial fibroblasts. We evaluated the expression of estrogen receptor alpha (ER) and the progesterone receptor (PR) by RT-PCR. ER and PR were strongly expressed in the fibroblasts and epithelial cells under treatment with 10(-8) M 17beta-estradiol (E(2)). Treatment with 10(-6) M J867 or ZK137316 upregulated the PR expression as did E(2), in contrast to treatment with 10(-6) M MPA, which caused a downregulation of PR in epithelial cells, but not in fibroblasts. In addition, the vascular endothelial growth factor (VEGF) release into the cell culture medium was analyzed by a VEGF-ELISA. VEGF which plays an important role in angiogenesis, is regulated by steroid hormones as well as hypoxia. E(2) stimulates VEGF release into the medium in both cell types. MPA reduces VEGF release significantly in the fibroblast cell culture, but increases it in the epithelial cell culture. ZK137316, in the presence or absence of E(2), reduces VEGF release in fibroblast cell culture. J867 increases the VEGF production in fibroblasts only in the presence of E(2). Both compounds show no significant effects, compared to E(2), in epithelial cell culture. The different results for the epithelial cells and fibroblasts indicate that the pharmacological effects of PR modulators (PRMs) and progesterone antagonists (PAs) may be cell specific and depend on the presence or absence of partial progestagenic agonistic activities. This observation opens up new perspectives for various clinical applications.

[1]  K. Chwalisz,et al.  Modulation of oestrogenic effects by progesterone antagonists in the rat uterus. , 1998, Human reproduction update.

[2]  S. Smith.  Angiogenesis, vascular endothelial growth factor and the endometrium. , 1998, Human reproduction update.

[3]  H. M. Beier,et al.  Establishment of a human endometrial cell culture system and characterization of its polarized hormone responsive epithelial cells , 1996, Cell and Tissue Research.

[4]  L. Giudice,et al.  Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. , 1999, The Journal of clinical endocrinology and metabolism.

[5]  P. Rogers,et al.  The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. , 1999, Molecular human reproduction.

[6]  K. Chwalisz,et al.  Antagonists for gynecological therapy , 1999 .

[7]  M. Breckwoldt,et al.  Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. , 1996, Human reproduction.

[8]  N. Weigel,et al.  Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  R. Stouffer,et al.  Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. , 1998, Human reproduction.

[10]  G. Stancel,et al.  Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. , 1996, Cancer research.

[11]  G. Ryffel,et al.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. , 1991, Nucleic acids research.

[12]  Y. Meng,et al.  Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.

[13]  K. Chwalisz,et al.  Studies on the mechanisms of action of progesterone antagonists. , 1986, Journal of steroid biochemistry.

[14]  H. Croxatto,et al.  Antiprogestins: mechanism of action and contraceptive potential. , 1996, Annual review of pharmacology and toxicology.

[15]  D. Charnock-Jones,et al.  Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. , 1993, Biology of reproduction.

[16]  M. Dawood,et al.  The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol. , 1998, Molecular human reproduction.

[17]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[18]  F. Galibert,et al.  Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. , 1987, Biochemical and biophysical research communications.

[19]  G. Dallenbach-Hellweg,et al.  Atlas der Histopathologie des Endometriums , 1985 .

[20]  M. Kusche,et al.  Marker molecules of human endometrial differentiation can be hormonally regulated under in-vitro conditions as in-vivo. , 1998, Human reproduction update.

[21]  D. Baird,et al.  Progesterone receptor subtype B is differentially regulated in human endometrial stroma. , 1998, Molecular human reproduction.

[22]  E. Baulieu,et al.  Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. , 1989, Fertility and sterility.

[23]  A. L. Goodman,et al.  Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. , 1997, Human reproduction.

[24]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[25]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[26]  D. McDonnell,et al.  RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. , 1994, The Journal of biological chemistry.

[27]  H. Klocker,et al.  Recent developments in molecular action of antihormones , 1998, Journal of Molecular Medicine.

[28]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.

[29]  A. Ahmed,et al.  Immunolocalisation of vascular endothelial growth factor in human endometrium. , 1994, Growth factors.

[30]  L. Tseng,et al.  Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells. , 1997, Biology of reproduction.

[31]  D. Hornung,et al.  Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. , 1998, Fertility and sterility.